DuPont de Nemours, Inc.

NYSE:DD Aktierapport

Börsvärde: US$19.5b

DuPont de Nemours Framtida tillväxt

Future kriterier kontrolleras 3/6

DuPont de Nemours förväntas öka intäkter och intäkter med 22.9% respektive 4% per år. EPS förväntas tillväxt med 24.4% per år. Avkastningen på eget kapital förväntas bli 7.7% om 3 år.

Viktig information

22.9%

Tillväxttakt i vinsten

24.43%

Tillväxttakt för EPS

Chemicals vinsttillväxt18.1%
Intäkternas tillväxttakt4.0%
Framtida avkastning på eget kapital7.67%
Bevakning av analytiker

Good

Senast uppdaterad15 Jun 2026

Senaste uppdateringarna om framtida tillväxt

Recent updates

Uppdatering av berättelse Jun 13

DD: Water Infrastructure Contracts And 2026 Guidance Will Support Further Upside

Analysts have nudged their average price target for DuPont de Nemours higher from $56.13 to about $57.07, reflecting updated assumptions for slightly different discount rates, revenue growth, profit margins, and future P/E levels. What's in the News DuPont's MemCor MBR system was selected for a major upgrade at the Riverstone Water Resource Recovery Facility in Sydney, supporting higher wastewater treatment capacity and long term environmental protection in a fast growing region.
Uppdatering av berättelse May 30

DD: Guidance Reaffirmation And Buybacks Will Support Future Upside Potential

Analysts have nudged their price target for DuPont de Nemours slightly higher to $64.00, citing updated assumptions for revenue growth, profit margins and future P/E that refine rather than overhaul their outlook on the stock. What's in the News Shareholders approved an amendment to the Certificate of Incorporation to allow a reverse stock split between 1-for-2 and 1-for-4, along with a corresponding reduction in authorized common shares at the May 21, 2026 AGM (Changes in Company Bylaws/Rules).
Seeking Alpha May 27

I See A Better DuPont, Not A Bargain

Summary DuPont de Nemours, Inc. is a leading science and materials company supplying specialized products to manufacturers, not direct consumers. DD recently sold its Aramids division, including Kevlar and Nomex, for $1.8 billion, streamlining its portfolio. AI and data center demand are driving significant growth in DD's microelectronics segment, making it a core business focus. After years of underperformance, DD shares have begun to outperform the S&P 500, supported by a reverse split and reaffirmed 2026 guidance. Read the full article on Seeking Alpha
Uppdatering av berättelse May 07

DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside

Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.
Uppdatering av berättelse Apr 23

DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside

Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Uppdatering av berättelse Apr 08

DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook

Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.
Uppdatering av berättelse Mar 24

DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside

Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Uppdatering av berättelse Mar 09

DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside

Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.
Uppdatering av berättelse Feb 23

DD: New Guidance And Product Pipeline Will Support Future Upside

Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.
Analysartikel Feb 17

There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings

The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...
Uppdatering av berättelse Feb 09

DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside

Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).
Uppdatering av berättelse Jan 26

DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity

Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).
Uppdatering av berättelse Jan 12

DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook

Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).
Uppdatering av berättelse Dec 27

DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity

Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.
Uppdatering av berättelse Dec 13

DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook

Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.
Uppdatering av berättelse Nov 29

DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground

Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.
Uppdatering av berättelse Nov 15

DD: Future Share Buybacks Will Unlock Value Amid Uncertainty

Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.
Analysartikel Nov 09

DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year

DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...
Uppdatering av berättelse Nov 01

DD: Qnity Separation And Water Solutions Will Drive Outperformance

Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.
Uppdatering av berättelse Oct 17

Electronics, Healthcare And Water Will Drive Future Success

Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.
Uppdatering av berättelse Sep 24

Electronics, Healthcare And Water Will Drive Future Success

Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.
Uppdatering av berättelse Sep 04

Electronics, Healthcare And Water Will Drive Future Success

As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.
Analysartikel Jul 23

Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...
Seeking Alpha Apr 07

DuPont: Upgrading To Hold Amid China Risks

Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking Alpha

Prognoser för vinst- och omsättningstillväxt

NYSE:DD - Analytikernas framtida uppskattningar och tidigare finansiella data (USD Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
12/31/20287,7448821,0051,50011
12/31/20277,4507959861,37415
12/31/20267,1687259911,37715
3/31/20266,9181329011,214N/A
12/31/20256,849571,0791,412N/A
9/30/20255,7224791,8941,900N/A
6/30/20255,5126301,7431,957N/A
3/31/20255,400-2341,5361,736N/A
12/31/20246,719-1311,5621,847N/A
9/30/202411,1614219731,837N/A
6/30/202411,3572601,2051,801N/A
3/31/202411,9814041,4202,037N/A
12/31/20236,614-1011,5931,918N/A
9/30/202312,2748956091,243N/A
6/30/202312,533963321991N/A
3/31/202312,7611,06579722N/A
12/31/202213,0171,012-74588N/A
9/30/202213,1591,0642,9721,335N/A
6/30/202213,0419601,0301,758N/A
3/31/202212,8239891,2642,112N/A
12/31/202112,5661,1591,4932,281N/A
9/30/202113,0701,453-3382,961N/A
6/30/202113,5001,2862,4113,393N/A
3/31/202113,685-1,4962,7513,755N/A
12/31/202011,128-1,3772,8314,095N/A
9/30/202015,792-2,6941,8253,372N/A
6/30/202017,589-2,4061,3362,980N/A
3/31/202019,768-1,147342,101N/A
12/31/201915,436-227N/A1,409N/A
9/30/201921,765-620N/A5,932N/A
6/30/201922,022-896N/A4,727N/A
3/31/201922,411230N/A6,894N/A
12/31/201822,594233N/A4,731N/A
9/30/201837,203-1,249N/A1,387N/A
6/30/201846,874-809N/A-711N/A
3/31/201854,851517N/A-2,826N/A
12/31/201711,67288N/A-765N/A
9/30/201755,4382,698N/A-641N/A
6/30/201752,5672,882N/A3,132N/A
3/31/201750,6854,672N/A5,385N/A
12/31/201648,1583,956N/A-2,957N/A
9/30/201646,6007,490N/A6,060N/A
6/30/201646,1538,056N/A7,219N/A
3/31/201647,1116,079N/A6,397N/A
12/31/201548,7787,294N/A7,607N/A
9/30/201551,7004,520N/A7,932N/A
6/30/201554,0694,084N/A7,196N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: DD s prognostiserade vinsttillväxt ( 22.9% per år) är över sparkvoten ( 3.5% ).

Resultat vs marknad: DD s intäkter ( 22.9% per år) förväntas växa snabbare än marknaden för US ( 18.5% per år).

Höga tillväxtresultat: DD s intäkter förväntas växa avsevärt under de kommande 3 åren.

Intäkt vs marknad: DD s intäkter ( 4% per år) förväntas växa långsammare än marknaden för US ( 12.7% per år).

Hög tillväxtintäkter: DD s intäkter ( 4% per år) förväntas växa långsammare än 20% per år.


Tillväxtprognoser för vinst per aktie


Framtida avkastning på eget kapital

Framtida ROE: DD s avkastning på eget kapital förväntas bli låg om 3 år ( 7.7 %).


Upptäck tillväxtföretag

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/06/15 19:43
Aktiekurs vid dagens slut2026/06/15 00:00
Intäkter2026/03/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

DuPont de Nemours, Inc. bevakas av 35 analytiker. 15 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
William SeleskyArgus Research Company
Patrick Duffy FischerBarclays
Michael LeitheadBarclays